Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

EndoS2 is a unique and conserved enzyme of serotype M49 group A Streptococcus that hydrolyses N-linked glycans on IgG and α1-acid glycoprotein

In English

Författare

  • Jonathan Sjögren
  • Weston B. Struwe
  • Eoin F. J. Cosgrave
  • Pauline M. Rudd
  • Martin Stervander
  • Maria Allhorn
  • Andrew Hollands
  • Victor Nizet
  • Mattias Collin

Summary, in English

Many bacteria have evolved ways to interact with glycosylation functions of the immune system of their hosts. Streptococcus pyogenes [GAS (group A Streptococcus)] secretes the enzyme EndoS that cleaves glycans on human IgG and impairs the effector functions of the antibody. The ndoS gene, encoding EndoS, has, until now, been thought to be conserved throughout the serotypes. However, in the present study, we identify EndoS2, an endoglycosidase in serotype M49 GAS strains. We characterized EndoS2 and the corresponding ndoS2 gene using sequencing, bioinformatics, phylogenetic analysis, recombinant expression and LC–MS analysis of glycosidic activity. This revealed that EndoS2 is present exclusively, and highly conserved, in serotype M49 of GAS and is only 37% identical with EndoS. EndoS2 showed endo-β-N-acetylglucosaminidase activity on all N-linked glycans of IgG and on biantennary and sialylated glycans of AGP (α1-acid glycoprotein). The enzyme was found to act only on native IgG and AGP and to be specific for free biantennary glycans with or without terminal sialylation. GAS M49 expression of EndoS2 was monitored in relation to carbohydrates present in the culture medium and was linked to the presence of sucrose. We conclude that EndoS2 is a unique endoglycosidase in serotype M49 and differs from EndoS of other GAS strains by targeting both IgG and AGP. EndoS2 expands the repertoire of GAS effectors that modify key glycosylated molecules of host defence.

Publiceringsår

2013

Språk

Engelska

Sidor

107-118

Publikation/Tidskrift/Serie

Biochemical Journal

Volym

455

Issue

1

Dokumenttyp

Artikel i tidskrift

Förlag

Portland Press

Ämne

  • Biological Sciences

Nyckelord

  • endo-β-N-acetylglucosaminidase
  • host–pathogen interaction
  • α1-acid glycoprotein
  • IgG glycosylation
  • Streptococcus pyogenes

Status

Published

Forskningsgrupp

  • Molecular Ecology and Evolution Lab
  • Infection and immunomodulation

ISBN/ISSN/Övrigt

  • ISSN: 0264-6021